ArticleCancer prevention research (Philadelphia, Pa.)2014

The PARP inhibitors, veliparib and olaparib, are effective chemopreventive agents for delaying mammary tumor development in BRCA1-deficient mice.

Ciric To et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.